← FDA Drug Approvals (Drugs@FDA)

ALOXI

NDA · New Drug Application · Sponsor: HELSINN HLTHCARE · Approved 2003-07-25

Drug application

FDA Application #

NDA021372

Application type

New Drug Application

Brand name

ALOXI

Generic name

PALONOSETRON HYDROCHLORIDE

Active ingredients

PALONOSETRON HYDROCHLORIDE

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

HELSINN HLTHCARE

Manufacturer

Cipla USA Inc.

First approval

2003-07-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown